Lewis Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Sell
2,670
-11
-0.4% -$11.2K 1.12% 20
2026
Q1
$2.47M Buy
2,681
+540
+25% +$547K 1.01% 24
2025
Q4
$2.3M Sell
2,141
-298
-12% -$285K 0.94% 25
2025
Q3
$1.86M Buy
2,439
+140
+6% +$104K 0.76% 30
2025
Q2
$1.79M Buy
2,299
+1,304
+131% +$1.01M 0.84% 29
2025
Q1
$822K Sell
995
-51
-5% -$42.4K 0.68% 38
2024
Q4
$808K Sell
1,046
-135
-11% -$112K 0.62% 42
2024
Q3
$1.05M Hold
1,181
0.76% 29
2024
Q2
$1.07M Sell
1,181
-10
-0.8% -$8K 0.82% 23
2024
Q1
$927K Buy
1,191
+11
+0.9% +$7.83K 0.76% 30
2023
Q4
$688K Buy
+1,180
New +$689K 0.63% 36

Other funds holding LLY

Lewis Asset Management's LLY Position: Q2 2026 in Review

Lewis Asset Management reduced its Eli Lilly (LLY) stake by 0.41% in Q2 2026, selling an estimated $11.2K and leaving 2,670 shares worth $3.2M. The position accounts for 1.12% of the portfolio, ranked #20.

Lewis Asset Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,170 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lewis Asset Management held 2,670 shares of Eli Lilly worth $3.2M as of Q2 2026.
  • Lewis Asset Management sold 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 1.12% of Lewis Asset Management's portfolio in Q2 2026, its #20 holding.
  • Lewis Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,170 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lewis Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.